CFDE Data Portal | Search LINC03104

	Label	Description
	LINC03104 Gene (Entity type)	ENSG00000274333 - long intergenic non-protein coding RNA 3104
	GSE200982 PLAC8 knockout 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE196343 metformin 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216540 fulvestrant 10 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE190384 GSE190386 fulvestrant 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 tunicamycin 6 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE126999 ARVCF knockdown 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228357 OGA knockdown 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233647 docetaxel UFERSA-PC3 DU145 4 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC03104

ENSG00000274333 - long intergenic non-protein coding RNA 3104

GSE200982 PLAC8 knockout 0 v 2 human dn

A Gene Set from LINCS

GSE196343 metformin 1 v 0 human dn

A Gene Set from LINCS

GSE216540 fulvestrant 10 v 6 human up

A Gene Set from LINCS

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE190384 GSE190386 fulvestrant 6 v 8 human dn

A Gene Set from LINCS

GSE102505 tunicamycin 6 v 2 human up

A Gene Set from LINCS

GSE126999 ARVCF knockdown 1 v 2 human dn

A Gene Set from LINCS

GSE228357 OGA knockdown 5 v 1 human dn

A Gene Set from LINCS

GSE233647 docetaxel UFERSA-PC3 DU145 4 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.